Exploring Experimental Hematology: May 2020 (Volume 85)
Exploring Experimental Hematology: Single-cell transcriptome in chronic myeloid leukemia: pseudotime analysis reveals evidence of embryonic and transitional stem cell states In this issue of Simply Blood, David Stachura is exploring Experimental Hematology by highlighting and deconstructing one of the journal’s latest manuscripts by first author Sarah Pagliaro, from the laboratory of Ali G. Turhan [ https://www.exphem.org/article/S0301-472X(20)30142-9/ ]. Reasons you should read this paper: About 15% of adult leukemia is categorized as Chronic Myeloid Leukemia (CML). It’s a clonal hematopoietic disease that usually results from a t(9;22) chromosomal translocation, causing the formation of the BCR-ABL oncogene. This tyrosine kinase (TK) is responsible for activating downstream molecular pathways that allow the uncontrollable growth of cancer cells. While tyrosine kinase inhibitor (TKI) drugs that can slow and stop the progression of the disease exist, many patients become immune to